Renal Cancer - Results from #840

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial. August 2, 2023

Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses? August 2, 2023

AI-generated R.E.N.A.L.+ score surpasses human-generated score in predicting renal oncologic outcomes. August 1, 2023

"Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC-mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas: Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications. August 1, 2023

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma. July 31, 2023

Artificial Intelligence-Based Hyper Accuracy Three-Dimensional (HA3D®) Models in Surgical Planning of Challenging Robotic Nephron-Sparing Surgery: A Case Report and Snapshot of the State-of-the-Art with Possible Future Implications. July 31, 2023

Prognostic value of preoperative microscopic hematuria in patients with non-metastatic renal cell carcinoma who underwent nephrectomy. July 28, 2023

A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma. July 28, 2023

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma. July 27, 2023

Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors. July 27, 2023

Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes. July 26, 2023

Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort. July 26, 2023

Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients. July 25, 2023

Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. July 25, 2023

Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma. July 24, 2023

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? July 24, 2023

Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy. July 21, 2023

A systematic review to summarize treatment patterns, guidelines, and characteristics of patients with renal cell carcinoma in the Asia-Pacific region. July 21, 2023

Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors. July 20, 2023

Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation. July 20, 2023

Page 43 of 457